Skip to main content
NGVT
NYSE Industrial Applications And Services

Ingevity Lifts 2026 EBITDA Guidance to $380M–$400M on Strong Q2, Absorbs $32M APT Impairment

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Positive
Importance info
8
Price
$70.19
Mkt Cap
$2.441B
52W Low
$39.735
52W High
$79.285
52W Position info
77% above low
Off High info
11% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

NGVT sits 77% above its 52-week low of $39.735.

Summary

Ingevity posted Q2 2026 net income of $35.3 million and raised its full-year adjusted EBITDA outlook to $380–$400 million, even as it recorded a $32.1 million impairment on its Advanced Polymer Technologies segment and disclosed a CEO stock sale plan.


Key Events · Earnings and Guidance · NGVT

  • Raised Full-Year EBITDA Guidance

    Driven by strong first-half execution across all segments, management lifted 2026 adjusted EBITDA guidance to $380–$400 million, up from prior expectations.

  • Q2 2026 Financial Results

    Net sales came in at $314.1 million, down 5% year-over-year due to divestitures, while net income reached $35.3 million, or $1.00 diluted EPS, with both Performance Materials and Advanced Polymer Technologies showing growth.

  • $32.1M Non-Cash Impairment on APT

    A long-lived asset impairment charge of $32.1 million was recorded for Advanced Polymer Technologies, as the ongoing sale process pointed to a lower recoverable value.

  • CEO Adopts 10b5-1 Trading Plan

    On May 13, 2026, CEO David H. Li adopted a Rule 10b5-1 plan that allows for the sale of up to 20,092 shares over the next year.


Analysis · NGVT · Industrial Applications And Services

A solid second quarter pushed net income to $35.3 million and gave management the confidence to raise full-year adjusted EBITDA guidance to $380–$400 million, underscoring the benefits of a streamlined portfolio after recent divestitures. The quarter did carry a blemish: a $32.1 million non-cash impairment on Advanced Polymer Technologies, reflecting a lower valuation as the sale process advances. Separately, the company disclosed a new CEO 10b5-1 trading plan and continued its aggressive buyback program, having repurchased $87.4 million in stock year-to-date. While the guidance raise grabs the headline, the impairment and insider selling plan add layers of complexity.

At the time of this filing, NGVT was trading at $70.19 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $39.74 to $79.29. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NGVT - Latest Insights

NGVT
Jul 29, 2026, 5:19 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $70.62
Real-time Price: $70.19 info
Change: -$0.430 (-0.61%) info
Market Cap: $2.441B info
NGVT
May 07, 2026, 4:26 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $74.07
Real-time Price: $70.19 info
Change: -$3.88 (-5%) info
Market Cap: $2.441B info
NGVT
May 06, 2026, 4:47 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $77.87
Real-time Price: $70.19 info
Change: -$7.68 (-10%) info
Market Cap: $2.441B info
NGVT
May 06, 2026, 4:35 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $77.87
Real-time Price: $70.19 info
Change: -$7.68 (-10%) info
Market Cap: $2.441B info
NGVT
Apr 15, 2026, 4:38 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $74.21
Real-time Price: $70.19 info
Change: -$4.02 (-5%) info
Market Cap: $2.441B info